1H-Pyrrole-3-carboxamide, 5-(2-amino-4-pyrimidinyl)-2-[2-chloro-5-(trifluoromethyl)phenyl]- manufacturers
- NMS-P953
-
- $3700.00
-
2026-07-27
- CAS:1403679-33-3
- Purity:
- Supply Ability: 10g
|
| | 1H-Pyrrole-3-carboxamide, 5-(2-amino-4-pyrimidinyl)-2-[2-chloro-5-(trifluoromethyl)phenyl]- Basic information |
| | 1H-Pyrrole-3-carboxamide, 5-(2-amino-4-pyrimidinyl)-2-[2-chloro-5-(trifluoromethyl)phenyl]- Chemical Properties |
| Boiling point | 602.8±65.0 °C(Predicted) | | density | 1.519±0.06 g/cm3(Predicted) | | pka | 11.92±0.50(Predicted) |
| | 1H-Pyrrole-3-carboxamide, 5-(2-amino-4-pyrimidinyl)-2-[2-chloro-5-(trifluoromethyl)phenyl]- Usage And Synthesis |
| Description | NMS-P953 is a JAK2 inhibitor, displaying significant tumor growth inhibition in SET-2 xenograft tumor model. NMS-P953 has a mechanism of action confirmed in vivo by typical modulation of known biomarkers, and with a favorable pharmacokinetic and safety profile. | | Uses | NMS-P953 (compound 28) is an orally active JAK2 inhibitor (IC50=0.008 μM) with antitumor activity[1]. | | IC 50 | JAK2: 0.008 μM (IC50) | | References | [1] Brasca M G, et al. Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors[J]. Bioorganic & Medicinal Chemistry, 2014, 22(17): 4998-5012. DOI:10.1016/j.bmc.2014.06.025 |
| | 1H-Pyrrole-3-carboxamide, 5-(2-amino-4-pyrimidinyl)-2-[2-chloro-5-(trifluoromethyl)phenyl]- Preparation Products And Raw materials |
|